Skip to main content

Table 2 Price trends for first-line, three-in-one FDCs and their component ARVs

From: Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets

 

Median (25th, 75th percentile) Regimen Prices* in USD

 

2002

2003

2004

2005

2006

2007

2008

3TC, NVP, d4T40

       

Generic NVP+3TC+d4T40

490

(486, 496)

418

(245, 489)

212

(184, 249)

209

(183, 255)

169

(150, 172)

114

(108, 130)

107

(97, 149)

Brand NVP+3TC+d4T40

  

640

(640, 648)

619

(619, 707)

618

(597, 746)

637

(370, 954)

897

(601, 1,219)

Generic FDC

 

165*

180

(143, 193)

180

(163, 214)

112

(112, 129)

83

(83, 102)

104

(80, 151)

ABC, 3TC, ZDV

       

Generic ABC+3TC+ZDV

  

1,083

(510, 1591)

1,101

(1,039, 1,212)

794

(744, 813)

568

(525, 626)

475

(436, 587)

Brand ABC+3TC+ZDV

 

1,669*

1,329

(1,329, 1,363)

1,286

(1,285, 1,387)

1,282

(978, 1,354)

984

(938, 991)

702

(681, 1,064)

Brand FDC

 

1,652*

1,483*

1,366

(1,366, 1,489)

1,363*

883

(883, 989)

 

EFV, FTC, TDF

       

Generic EFV + FTC/TDF

     

516

(417, 536)

464

(441, 487)

Brand EFV + FTC/TDF

   

781*

678

(636, 769)

593

(579, 624)

619

(573, 834)

Generic FDC

      

485*

Brand FDC

     

712*

613*

  1. *25th and 75th percentiles not calculated because n < 5 purchases